share_log

Bellerophon Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Theodore Wang(0.5%),Puissance Life Science Opportunities Fund VI(0%), etc.

Bellerophon Therapeutics | SC 13D/A:超过5%持股股东披露文件(修正)-Theodore Wang(0.5%),Puissance Life Science Opportunities Fund VI(0%)等

SEC announcement ·  2023/10/17 21:05
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息